Two researchers affiliated with UW School of Medicine were named to TIME's 100 most influential people for 2022.
A one-shot vaccine schedule could contribute greatly to the elimination of cervical cancer worldwide, researchers say.
The Seattle Tuberculosis Research Advancement Center will promote and coordinate studies across institutions in the city.
Paper in The Lancet offers guidance to help low- and middle-income countries cut early mortality from non-communicable diseases.
If medication supplies dwindle, hospitals worldwide should prioritize health equity and people at greatest risk, a new paper argues.
Project partners with African, Asian and Latin American countries to stay ahead of emerging zoonotic disease viruses.
Millions of people in low-income countries should have basic vaccine protection first, two bioethicists argue.
Naomi Nkinsi is one of 30 winners of a fellowship that had nearly 2,500 applicants. Winners receive up to $90,000.
An analysis argues that embracing an African-based ethic of solidarity will yield a fairer global response to disease outbreaks.
Virtual symposium March 23-24 will explore a new vision of collaboration against tuberculosis.